Listed

Xtant Medical Holdings, Inc.

XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$23.0m, Q2 FY2026
Operating income−$9.2m, Q2 FY2026
Net income−$9.4m, Q2 FY2026
Xtant Medical Holdings, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m25.0Revenue, Q3 FY2023, three months to 2023-09-30$25.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure28.1Revenue, Q4 FY2023, three months to 2023-12-31$28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure27.9Revenue, Q1 FY2024, three months to 2024-03-31$27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure29.9Revenue, Q2 FY2024, three months to 2024-06-30$29.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure27.9Revenue, Q3 FY2024, three months to 2024-09-30$27.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure31.5Revenue, Q4 FY2024, three months to 2024-12-31$31.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure32.9Revenue, Q1 FY2025, three months to 2025-03-31$32.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure35.4Revenue, Q2 FY2025, three months to 2025-06-30$35.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure33.3Revenue, Q3 FY2025, three months to 2025-09-30$33.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure32.4Revenue, Q4 FY2025, three months to 2025-12-31$32.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure20.9Revenue, Q1 FY2026, three months to 2026-03-31$20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure23.0Revenue, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Cost of revenue$m9.7Cost of revenue, Q3 FY2023, three months to 2023-09-30$9.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure11.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$11.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure10.6Cost of revenue, Q1 FY2024, three months to 2024-03-31$10.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure11.4Cost of revenue, Q2 FY2024, three months to 2024-06-30$11.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure11.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$11.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure15.5Cost of revenue, Q4 FY2024, three months to 2024-12-31$15.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure12.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$12.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure11.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$11.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure11.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$11.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure14.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$14.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure8.9Cost of revenue, Q1 FY2026, three months to 2026-03-31$8.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure9.7Cost of revenue, Q2 FY2026, three months to 2026-06-30$9.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Gross profit$m15.3Gross profit, Q3 FY2023, three months to 2023-09-30$15.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure17.1Gross profit, Q4 FY2023, three months to 2023-12-31$17.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure17.3Gross profit, Q1 FY2024, three months to 2024-03-31$17.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure18.6Gross profit, Q2 FY2024, three months to 2024-06-30$18.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure16.3Gross profit, Q3 FY2024, three months to 2024-09-30$16.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure16.0Gross profit, Q4 FY2024, three months to 2024-12-31$16.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure20.2Gross profit, Q1 FY2025, three months to 2025-03-31$20.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure24.3Gross profit, Q2 FY2025, three months to 2025-06-30$24.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure22.0Gross profit, Q3 FY2025, three months to 2025-09-30$22.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure17.8Gross profit, Q4 FY2025, three months to 2025-12-31$17.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure12.0Gross profit, Q1 FY2026, three months to 2026-03-31$12.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure13.3Gross profit, Q2 FY2026, three months to 2026-06-30$13.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Research and development$m0.5Research and development, Q3 FY2023, three months to 2023-09-30$490.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure0.5Research and development, Q4 FY2023, three months to 2023-12-31$492.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure0.5Research and development, Q1 FY2024, three months to 2024-03-31$527.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure0.6Research and development, Q2 FY2024, three months to 2024-06-30$636.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure0.7Research and development, Q3 FY2024, three months to 2024-09-30$701.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure0.5Research and development, Q4 FY2024, three months to 2024-12-31$522.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.4Research and development, Q1 FY2025, three months to 2025-03-31$443.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.6Research and development, Q2 FY2025, three months to 2025-06-30$566.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure0.6Research and development, Q3 FY2025, three months to 2025-09-30$634.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure0.5Research and development, Q4 FY2025, three months to 2025-12-31$459.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.4Research and development, Q1 FY2026, three months to 2026-03-31$435.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.7Research and development, Q2 FY2026, three months to 2026-06-30$695.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Operating income$m(3.4)Operating income, Q3 FY2023, three months to 2023-09-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure(3.8)Operating income, Q4 FY2023, three months to 2023-12-31−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure(3.5)Operating income, Q1 FY2024, three months to 2024-03-31−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure(2.9)Operating income, Q2 FY2024, three months to 2024-06-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure(3.8)Operating income, Q3 FY2024, three months to 2024-09-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(1.9)Operating income, Q4 FY2024, three months to 2024-12-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure1.1Operating income, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure4.6Operating income, Q2 FY2025, three months to 2025-06-30$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure2.5Operating income, Q3 FY2025, three months to 2025-09-30$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(0.9)Operating income, Q4 FY2025, three months to 2025-12-31−$944.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(2.9)Operating income, Q1 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(9.2)Operating income, Q2 FY2026, three months to 2026-06-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Interest expense$m0.8Interest expense, Q3 FY2023, three months to 2023-09-30$760.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure0.8Interest expense, Q4 FY2023, three months to 2023-12-31$818.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure0.8Interest expense, Q1 FY2024, three months to 2024-03-31$835.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure1.0Interest expense, Q2 FY2024, three months to 2024-06-30$992.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure1.2Interest expense, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure1.1Interest expense, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure1.0Interest expense, Q2 FY2025, three months to 2025-06-30$1.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure0.9Interest expense, Q3 FY2025, three months to 2025-09-30$904.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure0.7Interest expense, Q4 FY2025, three months to 2025-12-31$718.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2026, three months to 2026-03-31$599.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.5Interest expense, Q2 FY2026, three months to 2026-06-30$542.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Income tax$m(2.3)Income tax, Q3 FY2023, three months to 2023-09-30−$2.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure0.6Income tax, Q4 FY2023, three months to 2023-12-31$577.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2024-03-31$68.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$36.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$62.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2025, three months to 2025-03-31−$25.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.3Income tax, Q2 FY2025, three months to 2025-06-30$255.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure0.3Income tax, Q3 FY2025, three months to 2025-09-30$257.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure1.5Income tax, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$27.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$73.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Net income$m9.2Net income, Q3 FY2023, three months to 2023-09-30$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure(4.3)Net income, Q4 FY2023, three months to 2023-12-31−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure(4.4)Net income, Q1 FY2024, three months to 2024-03-31−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(3.9)Net income, Q2 FY2024, three months to 2024-06-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(5.0)Net income, Q3 FY2024, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure(3.2)Net income, Q4 FY2024, three months to 2024-12-31−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure0.1Net income, Q1 FY2025, three months to 2025-03-31$58.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure3.6Net income, Q2 FY2025, three months to 2025-06-30$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure1.3Net income, Q3 FY2025, three months to 2025-09-30$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure0.1Net income, Q4 FY2025, three months to 2025-12-31$57.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Net income, Q1 FY2026, three months to 2026-03-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure(9.4)Net income, Q2 FY2026, three months to 2026-06-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Diluted EPS$ per share0.07Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure(0.03)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure(0.04)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figurenot reported0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.02Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure0.01Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Basic EPS$ per share0.07Basic EPS, Q3 FY2023, three months to 2023-09-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figurenot reported(0.03)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure(0.03)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure(0.04)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figurenot reported0.00Basic EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure0.03Basic EPS, Q2 FY2025, three months to 2025-06-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure0.01Basic EPS, Q3 FY2025, three months to 2025-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(0.07)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure

Balance sheet

Cash and equivalents$9.9m, Q2 FY2026
Long-term debt$7.3m, Q2 FY2026
Shareholders' equity$40.0m, Q2 FY2026
Xtant Medical Holdings, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m8.7Cash and equivalents, Q3 FY2023, at 2023-09-30$8.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure5.7Cash and equivalents, FY2023, at 2023-12-31$5.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure4.5Cash and equivalents, Q1 FY2024, at 2024-03-31$4.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure5.4Cash and equivalents, Q2 FY2024, at 2024-06-30$5.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure6.6Cash and equivalents, Q3 FY2024, at 2024-09-30$6.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure6.2Cash and equivalents, FY2024, at 2024-12-31$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure5.0Cash and equivalents, Q1 FY2025, at 2025-03-31$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure6.9Cash and equivalents, Q2 FY2025, at 2025-06-30$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure10.4Cash and equivalents, Q3 FY2025, at 2025-09-30$10.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure17.1Cash and equivalents, FY2025, at 2025-12-31$17.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure12.1Cash and equivalents, Q1 FY2026, at 2026-03-31$12.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure9.9Cash and equivalents, Q2 FY2026, at 2026-06-30$9.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Current assets$m64.1Current assets, Q3 FY2023, at 2023-09-30$64.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure64.9Current assets, FY2023, at 2023-12-31$64.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure66.5Current assets, Q1 FY2024, at 2024-03-31$66.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019887.Report this figure69.0Current assets, Q2 FY2024, at 2024-06-30$69.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030663.Report this figure71.4Current assets, Q3 FY2024, at 2024-09-30$71.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure67.1Current assets, FY2024, at 2024-12-31$67.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure69.1Current assets, Q1 FY2025, at 2025-03-31$69.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure75.6Current assets, Q2 FY2025, at 2025-06-30$75.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure78.3Current assets, Q3 FY2025, at 2025-09-30$78.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure78.2Current assets, FY2025, at 2025-12-31$78.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure62.6Current assets, Q1 FY2026, at 2026-03-31$62.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure64.8Current assets, Q2 FY2026, at 2026-06-30$64.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Total assets$m92.0Total assets, Q3 FY2023, at 2023-09-30$92.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure92.6Total assets, FY2023, at 2023-12-31$92.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure93.9Total assets, Q1 FY2024, at 2024-03-31$93.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019887.Report this figure95.6Total assets, Q2 FY2024, at 2024-06-30$95.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001493152-24-030663.Report this figure98.9Total assets, Q3 FY2024, at 2024-09-30$98.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure93.8Total assets, FY2024, at 2024-12-31$93.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure95.8Total assets, Q1 FY2025, at 2025-03-31$95.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure103Total assets, Q2 FY2025, at 2025-06-30$103.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure106Total assets, Q3 FY2025, at 2025-09-30$106.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure94.1Total assets, FY2025, at 2025-12-31$94.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure78.0Total assets, Q1 FY2026, at 2026-03-31$78.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure79.7Total assets, Q2 FY2026, at 2026-06-30$79.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Current liabilities$m21.9Current liabilities, Q3 FY2023, at 2023-09-30$21.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure23.0Current liabilities, FY2023, at 2023-12-31$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure28.4Current liabilities, Q1 FY2024, at 2024-03-31$28.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019887.Report this figure28.3Current liabilities, Q2 FY2024, at 2024-06-30$28.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030663.Report this figure33.7Current liabilities, Q3 FY2024, at 2024-09-30$33.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure28.6Current liabilities, FY2024, at 2024-12-31$28.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure29.6Current liabilities, Q1 FY2025, at 2025-03-31$29.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure30.6Current liabilities, Q2 FY2025, at 2025-06-30$30.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure35.5Current liabilities, Q3 FY2025, at 2025-09-30$35.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure29.5Current liabilities, FY2025, at 2025-12-31$29.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure18.8Current liabilities, Q1 FY2026, at 2026-03-31$18.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure30.0Current liabilities, Q2 FY2026, at 2026-06-30$30.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Total liabilities$m37.3Total liabilities, Q3 FY2023, at 2023-09-30$37.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure41.3Total liabilities, FY2023, at 2023-12-31$41.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure46.3Total liabilities, Q1 FY2024, at 2024-03-31$46.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019887.Report this figure50.6Total liabilities, Q2 FY2024, at 2024-06-30$50.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001493152-24-030663.Report this figure53.2Total liabilities, Q3 FY2024, at 2024-09-30$53.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure50.9Total liabilities, FY2024, at 2024-12-31$50.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure52.0Total liabilities, Q1 FY2025, at 2025-03-31$52.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure55.0Total liabilities, Q2 FY2025, at 2025-06-30$55.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure55.9Total liabilities, Q3 FY2025, at 2025-09-30$55.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure43.2Total liabilities, FY2025, at 2025-12-31$43.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure29.4Total liabilities, Q1 FY2026, at 2026-03-31$29.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure39.7Total liabilities, Q2 FY2026, at 2026-06-30$39.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Long-term debt$m14.4Long-term debt, Q3 FY2023, at 2023-09-30$14.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure17.2Long-term debt, FY2023, at 2023-12-31$17.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-06, accession 0001493152-25-009391.Report this figure16.8Long-term debt, Q1 FY2024, at 2024-03-31$16.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019887.Report this figure21.8Long-term debt, Q2 FY2024, at 2024-06-30$21.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030663.Report this figure19.1Long-term debt, Q3 FY2024, at 2024-09-30$19.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure22.0Long-term debt, FY2024, at 2024-12-31$22.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure22.2Long-term debt, Q1 FY2025, at 2025-03-31$22.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure22.3Long-term debt, Q2 FY2025, at 2025-06-30$22.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure17.4Long-term debt, Q3 FY2025, at 2025-09-30$17.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure11.0Long-term debt, FY2025, at 2025-12-31$11.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure8.1Long-term debt, Q1 FY2026, at 2026-03-31$8.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure7.3Long-term debt, Q2 FY2026, at 2026-06-30$7.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Current portion of debt$m2.8Current portion of debt, Q3 FY2023, at 2023-09-30$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figurenot reportednot reportednot reported2.8Current portion of debt, Q3 FY2024, at 2024-09-30$2.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figurenot reportednot reportednot reportednot reported3.5Current portion of debt, FY2025, at 2025-12-31$3.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure3.7Current portion of debt, Q1 FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure3.7Current portion of debt, Q2 FY2026, at 2026-06-30$3.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure
Shareholders' equity$m54.7Shareholders' equity, Q3 FY2023, at 2023-09-30$54.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure51.3Shareholders' equity, FY2023, at 2023-12-31$51.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001493152-26-013792.Report this figure47.7Shareholders' equity, Q1 FY2024, at 2024-03-31$47.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure45.0Shareholders' equity, Q2 FY2024, at 2024-06-30$45.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure45.7Shareholders' equity, Q3 FY2024, at 2024-09-30$45.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure43.0Shareholders' equity, FY2024, at 2024-12-31$43.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure43.9Shareholders' equity, Q1 FY2025, at 2025-03-31$43.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure48.5Shareholders' equity, Q2 FY2025, at 2025-06-30$48.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure50.4Shareholders' equity, Q3 FY2025, at 2025-09-30$50.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure51.0Shareholders' equity, FY2025, at 2025-12-31$51.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure48.6Shareholders' equity, Q1 FY2026, at 2026-03-31$48.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure40.0Shareholders' equity, Q2 FY2026, at 2026-06-30$40.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure

Cash flow

Operating cash flow−$7.3m, Q2 FY2026
Capital expenditure$247.0k, Q2 FY2026
Xtant Medical Holdings, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(3,834)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001493152-24-044764. Derived: 9-month figure less the 6-month figure.Report this figure(915)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$915.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure(5,755)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure(5,088)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001641172-25-023120. Derived: 6-month figure less the 3-month figure.Report this figure(1,718)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Report this figure665Operating cash flow, Q4 FY2024, three months to 2024-12-31$665.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure1,278Operating cash flow, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure1,276Operating cash flow, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figure4,612Operating cash flow, Q3 FY2025, three months to 2025-09-30$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Report this figure5,380Operating cash flow, Q4 FY2025, three months to 2025-12-31$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure(2,114)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure(7,308)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k223Capital expenditure, Q3 FY2023, three months to 2023-09-30$223.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001493152-24-044764. Derived: 9-month figure less the 6-month figure.Report this figure363Capital expenditure, Q4 FY2023, three months to 2023-12-31$363.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0001493152-25-009391. Derived: 12-month figure less the 9-month figure.Report this figure773Capital expenditure, Q1 FY2024, three months to 2024-03-31$773.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure564Capital expenditure, Q2 FY2024, three months to 2024-06-30$564.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001641172-25-023120. Derived: 6-month figure less the 3-month figure.Report this figure2,104Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Report this figure672Capital expenditure, Q4 FY2024, three months to 2024-12-31$672.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure1,191Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure366Capital expenditure, Q2 FY2025, three months to 2025-06-30$366.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figure430Capital expenditure, Q3 FY2025, three months to 2025-09-30$430.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001493152-25-021512. Derived: 9-month figure less the 6-month figure.Report this figure395Capital expenditure, Q4 FY2025, three months to 2025-12-31$395.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013792. Derived: 12-month figure less the 9-month figure.Report this figure194Capital expenditure, Q1 FY2026, three months to 2026-03-31$194.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure247Capital expenditure, Q2 FY2026, three months to 2026-06-30$247.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-036981. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)140.26m, Q2 FY2026
Xtant Medical Holdings, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares93.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3093,278,610 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-041077.Report this figure109Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31108,893,588 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001493152-24-019887.Report this figure109Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30108,897,048 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001493152-24-030663.Report this figure136Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30135,663,274 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001493152-24-044764.Report this figure130Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31130,201,251 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001641172-25-009674.Report this figure130Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30130,269,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001641172-25-023120.Report this figure135Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30135,100,233 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure143Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31143,335,114 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure149Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30148,574,242 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure150Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30150,377,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001493152-25-021512.Report this figure140Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31140,058,787 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001493152-26-022604.Report this figure140Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30140,258,667 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure

Shares outstanding: 140.29mShares outstanding, period not labelled, at 2026-08-07140,287,960 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-036981.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.